immunity · February 6, 2026
Cathelicidin Peptides in Innate Immune Research
Cathelicidins are cationic host-defense peptides with conserved precursor organization and diverse mature sequences. In research models, they are studied as antimicrobial effectors, immunomodulatory signals, and regulators of barrier tissue responses.
Overview and family organization
Cathelicidins are a family of host-defense peptides found across vertebrate species and studied primarily in the context of innate immunity, epithelial barrier biology, and leukocyte function. Their name reflects a conserved N-terminal cathelin-like domain within the inactive precursor, paired with a variable C-terminal peptide that is released by proteolytic processing. This architecture distinguishes cathelicidins from other antimicrobial peptide families, such as defensins, whose precursor organization and disulfide-rich folds differ substantially.
The best-characterized human cathelicidin gene is CAMP, which encodes the precursor hCAP18. Proteolytic cleavage can generate LL-37, a 37-residue amphipathic peptide beginning with two leucines. In mice, the orthologous cathelicidin is commonly referred to as CRAMP. Other mammals express multiple cathelicidins, including diverse bovine, porcine, equine, and avian peptides with distinct lengths, charges, secondary structures, and antimicrobial spectra. This diversity has made the family useful for comparative studies of host-defense evolution and peptide structure–function relationships.
Expression in immune and barrier systems
Cathelicidin expression is most often examined in neutrophils, monocytes, macrophages, keratinocytes, respiratory epithelium, intestinal epithelium, and other barrier-associated cell types. In neutrophils, cathelicidin precursors are stored in granules and can be released during degranulation or extracellular trap formation in experimental systems. Epithelial expression is frequently inducible, with investigators observing regulation by microbial products, inflammatory cytokines, differentiation state, and environmental cues relevant to barrier tissues.
Vitamin D pathway signaling is an important regulatory axis for human CAMP expression in several in vitro models. Activation of the vitamin D receptor has been associated with increased CAMP transcription in keratinocytes, macrophages, and epithelial cultures, although the strength and context of this effect vary by cell type and experimental conditions. Species differences are important: regulatory elements controlling CAMP in humans are not always conserved in rodents, which complicates direct extrapolation between model systems.
Cathelicidins are also detected in mucosal secretions and wound-associated fluids in preclinical and ex vivo studies. Their localization at surfaces exposed to microorganisms supports their classification as first-line innate immune effectors. However, their biological activity depends strongly on local salt concentration, protease activity, binding to host molecules, and the presence of microbial membranes or biofilm matrices.
Antimicrobial mechanisms in research models
In simplified in vitro systems, many cathelicidin peptides disrupt bacterial membranes through electrostatic attraction to negatively charged microbial surfaces followed by membrane insertion, curvature stress, pore formation, or broader bilayer destabilization. Amphipathic helicity is a recurring feature of LL-37 and related peptides, but cathelicidin structures are not uniform across species; some mature peptides are linear, proline-rich, tryptophan-rich, or cyclic.
Beyond direct membrane disruption, investigators have reported intracellular and biofilm-associated effects for selected cathelicidins. Some peptides interfere with bacterial cell wall processes, nucleic acid-associated functions, or metabolic pathways in model systems, while others alter biofilm formation, architecture, or dispersal. These observations are highly assay-dependent. Peptide concentration, medium composition, serum proteins, ionic strength, and inoculum size can materially change apparent activity.
Cathelicidins have also been studied against fungi, enveloped viruses, and parasites in preclinical assays. In viral systems, proposed mechanisms include disruption of viral envelopes, inhibition of entry, aggregation of virions, or altered host-cell signaling. For fungi, membrane interaction and immune-cell recruitment have been explored. The family should not be treated as mechanistically uniform; the mature peptide sequence, organism tested, and assay platform determine much of the observed phenotype.
Immunomodulatory activities
A central reason cathelicidins remain prominent in immunity research is that they are not simply antimicrobial detergents. In cell culture and animal models, LL-37 and related peptides can influence chemotaxis, cytokine production, inflammasome-associated pathways, phagocytosis, wound-associated cell migration, angiogenesis-related responses, and antigen-presenting cell behavior. These effects often occur at concentrations distinct from those required for direct microbial killing.
LL-37 has been reported to interact with multiple host targets, including formyl peptide receptor 2, P2X7-associated signaling contexts, epidermal growth factor receptor-related pathways, and glycosaminoglycans, though the interpretation of receptor specificity remains complex. The peptide is highly cationic and can bind nucleic acids, lipopolysaccharide, lipoteichoic acid, and extracellular matrix components. These binding events may either dampen or amplify inflammatory readouts depending on the molecular complex formed and the cell type under study.
One extensively studied phenomenon is cathelicidin-mediated nucleic acid complexation. LL-37 can protect host or microbial DNA and RNA from degradation and facilitate uptake by immune cells in vitro. In plasmacytoid dendritic cell models, such complexes have been associated with type I interferon pathway activation. This has made cathelicidin biology relevant to studies of sterile inflammation and autoimmunity, while also underscoring that host-defense peptides can have context-dependent pro-inflammatory properties.
Experimental considerations and limitations
Cathelicidin experiments require careful control of peptide quality and formulation. Synthetic peptides may differ in purity, counterions, oxidation state, aggregation behavior, and residual solvent content. Adsorption to plasticware, degradation by proteases, and batch-to-batch variation can affect results. For LL-37 in particular, oligomerization and binding to serum proteins can shift apparent potency in both antimicrobial and mammalian-cell assays.
Assay conditions are a major source of non-reproducibility. Standard microbiological media may suppress cationic peptide activity because of salt content, divalent cations, or protein binding. Conversely, low-ionic-strength buffers can exaggerate membrane-disruptive effects relative to complex biological fluids. Mammalian cytotoxicity assays also need appropriate controls, since membrane-active peptides can interfere with viability dyes, mitochondrial readouts, or luminescent endpoints.
Species selection is another limitation. Mouse CRAMP is often used to model cathelicidin function in vivo, but it is not identical to human LL-37 in sequence, regulation, or activity profile. Knockout and transgenic models are informative for pathway mapping, yet differences in microbiota composition, barrier physiology, and immune-cell distribution can influence phenotypes. Comparative studies across species can be useful when they are designed to address these differences rather than obscure them.
Current research directions
Current cathelicidin research is moving toward systems-level interpretation. Rather than treating these peptides as isolated antimicrobial agents, investigators increasingly examine their roles within tissue microenvironments containing microbes, epithelial cells, immune cells, extracellular matrix, proteases, and soluble inflammatory mediators. Organoid cultures, air–liquid interface epithelial models, microfluidic infection systems, and spatial transcriptomic approaches are expanding the experimental vocabulary for this family.
Structure-guided studies remain active, particularly for defining how charge distribution, hydrophobic moment, helicity, and protease resistance shape activity. Analogs and fragments are frequently used as probes to separate antimicrobial effects from immunomodulatory signaling in vitro. Such work is valuable for mechanism discovery, provided that modified peptides are not assumed to recapitulate the parent molecule’s behavior in complex tissues.
Overall, cathelicidins occupy a boundary between antimicrobial chemistry and immune regulation. Preclinical studies suggest that their biological significance arises from this dual character: they can interact directly with microbes while also shaping host-cell responses. For laboratory immunity research, the family offers a compact but complex model of how barrier defenses integrate biochemical, cellular, and environmental signals.